Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.

Liknande verk

• High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
  av: Blackman, D, et al.
  Publicerad: (2003)
• The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
  av: Abizaid, A, et al.
  Publicerad: (2012)
• Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
  av: Blackman, D, et al.
  Publicerad: (2004)
• Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
  av: Tanabe, K, et al.
  Publicerad: (2005)
• Safety of MRI early after implantation of a drug-eluting stent.
  av: Porto, I, et al.
  Publicerad: (2004)